Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

India’s Technology Transfer Framework: National IPR Policy, ANRF, and the 2025 Patent Rules

India’s university technology-transfer framework runs on the 2016 National IPR Policy, ANRF’s 2024 commercialisation mandate, and the 2025 Patents (Amendment) Rules — with no Bayh-Dole-equivalent statute tying them together.

India’s approach to university technology transfer is built on three layers that don’t always get discussed together: a 2016 national policy framework, a 2023-24 overhaul of how public research funding itself is governed, and a 2025 procedural reform to the patent statute that changes how disputes are enforced. Read separately, each is a narrow legal or administrative update. Read together, they describe where India currently sits relative to the more centralized technology-transfer models covered elsewhere in this series — Germany’s Fraunhofer-Gesellschaft, France’s SATT network, Japan’s TLO Act, and South Korea’s university TLO system among them.

What “technology transfer” means in the Indian policy context

Unlike the United States, India has no single Bayh-Dole-equivalent statute that comprehensively assigns ownership of publicly funded inventions to the performing institution and sets uniform disclosure, election, and march-in obligations. India has, at various points, considered and drafted such legislation (the Protection and Utilisation of Publicly Funded Intellectual Property Bill was introduced but never enacted). In its absence, Indian technology transfer runs on a looser stack of instruments: the Technology Licensing Office (TLO) or IPR cell that individual institutions establish under their own policies, sector-specific funding-agency IP guidelines (DBT, DST, CSIR, and now ANRF each have their own), and the general Patents Act, 1970 that governs patentability, examination, and enforcement regardless of who owns the invention. The result is an ecosystem that looks less like the UK’s centrally coordinated Research England model and closer to the institutional heterogeneity Canada has moved away from under NSERC’s IP-policy diversity push — individual Indian Institutes of Technology, central universities, and CSIR laboratories each set their own invention-disclosure, ownership, and revenue-sharing rules, with the national instruments below providing direction rather than a single binding structure.

The National IPR Policy (2016): the overarching framework

India’s National Intellectual Property Rights Policy was adopted by the Union Cabinet in May 2016 under the banner “Creative India; Innovative India.” It is not itself a law; it is a whole-of-government policy statement that assigns the Department for Promotion of Industry and Internal Trade (DPIIT), within the Ministry of Commerce and Industry, as the nodal department for IP matters, and creates the Cell for IPR Promotion and Management (CIPAM) as DPIIT’s implementing arm.

The policy sets out seven objectives spanning public awareness, IP generation, a stronger legal and legislative framework, administration and management modernisation, commercialisation of IP, enforcement and adjudication, and human capital development. For research administrators, the two most relevant strands are IP generation and commercialisation: the policy explicitly frames universities and R&D institutions as sources of patentable IP that the innovation system should be actively converting into licensed, commercialised technology rather than allowing to sit as unexploited filings — the same “patent that never gets licensed” problem that motivates commercialisation-readiness practice everywhere, and that Bayh-Dole’s diligence obligations were designed to prevent in the US context. The Policy does not itself create the mechanisms to do this at the university level; it names the direction and leaves DPIIT/CIPAM, DST, and now ANRF to build the machinery.

ANRF and the patent-commercialisation mandate

The most significant recent shift in that machinery is institutional rather than legislative. The Anusandhan National Research Foundation (ANRF) was established by the ANRF Act, 2023 (assented 15 August 2023, commenced 1 December 2023) and became operational through 2024, absorbing the former Science and Engineering Research Board (SERB). ANRF sits under the administrative umbrella of the Department of Science and Technology (DST) and is India’s new apex body for directing research funding, innovation, and entrepreneurship across disciplines — not a technology-transfer office itself, but a funding body whose stated mandate explicitly extends past basic research into fostering translational research, industry linkages, and the conversion of publicly funded R&D into commercialisable outcomes.

For a research administrator, the practical significance is this: where SERB’s programs were largely discipline-based project funding, ANRF’s founding mandate places commercialisation and industry collaboration alongside basic-research funding as a first-order objective rather than an afterthought handled downstream by an institution’s own TTO. That reframes how proposal review, milestone reporting, and institutional IP policy interact with a national funder for the first time in India at this scale. See the companion guide on ANRF’s governance, structure, and funding model and on DST’s role and schemes for the funding-administration detail this page does not repeat.

Independent commentary on ANRF’s early implementation — including analysis from Indian IP-policy researchers — has noted that India’s research output and patent filings have grown substantially over the past decade, but the research-to-commercialisation pipeline remains structurally weak relative to filing volume, and R&D expenditure remains a small share of GDP relative to peer economies. ANRF’s founding premise is that closing that gap requires a funding body actively steering toward commercialisation outcomes, not just publication and filing counts — a debate that is still unfolding in Indian policy circles as of this writing, including public criticism that ANRF’s funding structure (which anticipates a large share of its corpus coming from non-government, including private-sector, sources) risks skewing research priorities toward commercially attractive fields.

University and institutional TTO landscape

Because India has no single statute forcing uniform institutional practice, the maturity of IP cells and TTOs varies enormously by institution. The IITs, several central universities, and CSIR laboratories operate established IP management and licensing functions with their own invention disclosure processes, inventor revenue-share policies, and outside patent-counsel relationships — structurally similar in function, if not in scale or funding, to how a mature Western TTO evaluates and prices a licence, even if the deal volume differs by orders of magnitude. Many smaller state universities and colleges have far thinner infrastructure, if any, which is precisely the gap the National IPR Policy’s “commercialisation” objective and ANRF’s mandate are both aimed at closing from the top down, in the absence of a Bayh-Dole-style statutory floor that would otherwise force every federally funded institution to build one.

The Patents (Amendment) Rules, 2025: decriminalisation and civil adjudication

DPIIT published the Draft Patents (Amendment) Rules, 2025 in the Official Gazette on 18 July 2025 for public consultation, with comments invited through 17 August 2025. The Central Government notified the final Patents (Amendment) Rules, 2025 on 25 November 2025.

It is worth being precise about what these rules actually do, because the framing of “startup incentives” sometimes attached to this reform in secondary commentary is not what the rules themselves are principally about. Their core purpose is to operationalise the Jan Vishwas (Amendment of Provisions) Act, 2023 as it applies to the Patents Act, 1970. The Jan Vishwas Act decriminalised a range of minor offences across more than 40 central statutes, including several Patents Act provisions (Sections 120–123) that previously carried criminal penalties, replacing them with a civil, administrative-adjudication framework and monetary fines. The 2025 Rules build the procedural machinery for that shift: they define an Adjudicating Officer (Rule 107B) and Appellate Authority, enable electronic filing of complaints, require adjudicating officers to issue notices and conduct inquiries — including online hearings — and set an expectation that adjudication concludes within roughly three months.

This is a genuine and useful reform for predictability and enforcement cost, but research administrators should not confuse it with a startup-fee or examination-incentive package. Those incentives already exist under the Patents Rules, 2003 as separately amended over the years: reduced statutory fees for individual applicants, startups, and small entities, and eligibility for expedited examination requests for startup-owned applications. The 2025 amendment does not change that fee schedule; it changes how alleged violations of the Act (such as false representation as a patentee or improper use of the term “patent office”) are investigated and penalised.

The 2025 Rules also arrived roughly a year after a separate, earlier reform: the Patents (Amendment) Rules, 2024, effective 15 March 2024, which shortened the deadline to file a request for examination from 48 months to 31 months from priority date for applications filed after that date, introduced a certificate-of-inventorship option, and adjusted grace-period and pre-grant opposition procedures. Together, the 2024 and 2025 amendments represent two distinct tracks of the same modernisation effort — procedural speed on one side, enforcement mechanics on the other — rather than a single “2025 reform package.”

Digitisation, AI-assisted tools, and examination pendency

The Indian Patent Office (part of the Office of the Controller General of Patents, Designs and Trade Marks, CGPDTM) has pursued visible modernisation over the past decade: online filing, centralised application allocation, and expanded use of video hearings. Examination pendency nonetheless remains a genuine, actively reported problem — multiple Indian IP-law commentators tracking the 2024–2025 annual figures have flagged a sharp fall in the number of applications actually examined year-over-year, attributed largely to examiner staffing shortfalls rather than a lack of digital tooling.

Separately, in February 2025 the Patent Office issued Revised Guidelines for Examination of Computer-Related Inventions (CRIs), clarifying the Section 3(k) patentability test applied to software and AI/machine-learning inventions. It is worth distinguishing this clearly: the February 2025 CRI guidelines govern how examiners assess the patentability of AI-related inventions submitted by applicants — they are not the same thing as the Patent Office deploying AI tools internally to search prior art or triage its own backlog. Vendors and commentators have discussed machine-learning-assisted prior-art search and classification as a direction the Office is moving in as part of broader digitisation, but a discrete, dated, official program specifically described as “AI-aided examination to clear the backlog” is not yet something this guide can point to a verifiable primary source for as of this writing; treat that framing as directional industry commentary rather than a confirmed CGPDTM initiative, and expect this specific area to keep changing quickly.

How India’s framework compares internationally

Placed alongside the other national models in this series, India’s current stage is closer to “coordinating instruments layered onto institutional autonomy” than to a single binding statute or a centrally funded intermediary network. Germany’s Fraunhofer-Gesellschaft and France’s SATT companies both centralise applied-research commercialisation through dedicated, professionally staffed intermediary organisations funded specifically for that purpose. Japan’s TLO Act and South Korea’s university TLO system both followed the US Bayh-Dole precedent reasonably closely, giving universities clear statutory title to publicly funded inventions. India, by contrast, has no equivalent statutory ownership floor: the National IPR Policy sets direction, ANRF now attaches a commercialisation mandate to national funding decisions, and the 2024/2025 Patents Rules amendments improve the mechanics of the patent system itself — but the underlying question of who owns a publicly funded Indian invention, and what obligations attach to that ownership, is still governed institution-by-institution rather than by a single national instrument, closer to the pre-reform heterogeneity that Canada’s own IP-policy-diversity debate has wrestled with than to the UK’s or Taiwan/Singapore’s more centrally coordinated arrangements (see Taiwan’s ITRI vs. Singapore’s A*STAR).

Frequently asked questions

Is India’s National IPR Policy a law?

No. It is a Union Cabinet-approved policy statement (2016), not a statute. It sets objectives and assigns implementation responsibility (principally to DPIIT/CIPAM) but does not itself create binding legal obligations on universities or inventors the way a statute like the Patents Act does.

Does India have a Bayh-Dole equivalent?

Not currently in force. A bill to create one — the Protection and Utilisation of Publicly Funded Intellectual Property Bill — was introduced in the past but was never enacted. Ownership and disclosure obligations for publicly funded inventions are instead set by individual institutional policy and by the terms of specific funding-agency grant conditions.

What does ANRF actually do differently from SERB on IP and commercialisation?

SERB funded research primarily along disciplinary lines. ANRF, as SERB’s statutory successor from 2023–24, carries an explicit mandate to foster translational research, industry collaboration, and commercialisation of research outputs alongside basic-research funding — a different first-order framing rather than a narrow technical change to how projects are scored.

What do the Patents (Amendment) Rules, 2025 change for a university inventor?

Directly, very little at the level of filing or prosecuting a patent application. The rules build the civil-adjudication machinery (Adjudicating Officer, electronic complaint filing, defined inquiry timelines) that now applies to certain decriminalised offences under the Patents Act, following the Jan Vishwas Act, 2023. They do not change examination timelines, fees, or startup incentives, which are governed separately.

Is the Indian Patent Office using AI to clear its backlog?

The Office has pursued broader digitisation (e-filing, centralised allocation, video hearings) and issued revised guidance (February 2025) on how examiners should assess AI/machine-learning inventions’ patentability. Reporting on a discrete, official AI-assisted examination or prior-art-search program specifically credited with reducing pendency is not yet verifiable against a primary CGPDTM source as of this writing; pendency itself is still widely reported as a live problem, driven mainly by examiner staffing levels.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →